Literature DB >> 19628940

Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through Life Study.

Nicolas Cherbuin1, Chantal Reglade-Meslin, Rajeev Kumar, Patricia Jacomb, Simon Easteal, Helen Christensen, Perminder Sachdev, Kaarin J Anstey.   

Abstract

AIMS: The aim of this study was to identify physical and mental health and lifestyle predictors of transition from normal cognition to mild cognitive disorder (MCD).
METHODS: A total of 2,082 individuals, aged 60-64 years, were assessed at 2 time-points 4 years apart for mild cognitive impairment (MCI) and other MCDs.
RESULTS: The main predictors of conversion to MCI and to other mild cognitive disorders were past alcohol intake, current anxiety and depression medication, increased systolic blood pressure, and past smoking.
CONCLUSION: Participants with a history of smoking or harmful alcohol consumption, hypertension, or who took medication for anxiety or depression were at increased risk of transitioning to MCI or any MCD. Strategies targeted at managing the above risk factors may have benefits in preventing mild cognitive decline in relatively healthy middle-aged individuals living in the community. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19628940     DOI: 10.1159/000229025

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  29 in total

1.  Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.

Authors:  Jason J Corneveaux; Amanda J Myers; April N Allen; Jeremy J Pruzin; Manuel Ramirez; Anzhelika Engel; Michael A Nalls; Kewei Chen; Wendy Lee; Kendria Chewning; Stephen E Villa; Hunsar B Meechoovet; Jill D Gerber; Danielle Frost; Hollie L Benson; Sean O'Reilly; Lori B Chibnik; Joshua M Shulman; Andrew B Singleton; David W Craig; Kendall R Van Keuren-Jensen; Travis Dunckley; David A Bennett; Philip L De Jager; Christopher Heward; John Hardy; Eric M Reiman; Matthew J Huentelman
Journal:  Hum Mol Genet       Date:  2010-06-09       Impact factor: 6.150

Review 2.  The relationship between blood pressure and cognitive function.

Authors:  Vera Novak; Ihab Hajjar
Journal:  Nat Rev Cardiol       Date:  2010-10-26       Impact factor: 32.419

3.  Anxiety symptoms and risk of dementia and mild cognitive impairment in the oldest old women.

Authors:  Ahmed M Kassem; Mary Ganguli; Kristine Yaffe; Joseph T Hanlon; Oscar L Lopez; John W Wilson; Kristine Ensrud; Jane A Cauley
Journal:  Aging Ment Health       Date:  2017-01-10       Impact factor: 3.658

4.  Anxiety symptoms and risk of cognitive decline in older community-dwelling men.

Authors:  Ahmed M Kassem; Mary Ganguli; Kristine Yaffe; Joseph T Hanlon; Oscar L Lopez; John W Wilson; Jane A Cauley
Journal:  Int Psychogeriatr       Date:  2017-04-09       Impact factor: 3.878

5.  Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Sarah R Gillett; Evan L Thacker; Abraham J Letter; Leslie A McClure; Virginia G Wadley; Frederick W Unverzagt; Brett M Kissela; Richard E Kennedy; Stephen P Glasser; Deborah A Levine; Mary Cushman
Journal:  Clin Neuropsychol       Date:  2015-05-15       Impact factor: 3.535

6.  Alcohol effects on cognitive change in middle-aged and older adults.

Authors:  Faika Zanjani; Brian G Downer; Tina M Kruger; Sherry L Willis; K Warner Schaie
Journal:  Aging Ment Health       Date:  2012-08-30       Impact factor: 3.658

Review 7.  BioAge: toward a multi-determined, mechanistic account of cognitive aging.

Authors:  Correne A DeCarlo; Holly A Tuokko; Dorothy Williams; Roger A Dixon; Stuart W S MacDonald
Journal:  Ageing Res Rev       Date:  2014-09-30       Impact factor: 10.895

8.  Cognition and Hemodynamics.

Authors:  Vera Novak
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-10

9.  Emergence of mild cognitive impairment in late middle-aged adults in the wisconsin registry for Alzheimer's prevention.

Authors:  Rebecca L Koscik; Asenath La Rue; Erin M Jonaitis; Ozioma C Okonkwo; Sterling C Johnson; Barbara B Bendlin; Bruce P Hermann; Mark A Sager
Journal:  Dement Geriatr Cogn Disord       Date:  2014-02-20       Impact factor: 2.959

Review 10.  Impact of Antidepressant Use on the Trajectory of Alzheimer's Disease: Evidence, Mechanisms, and Therapeutic Implications.

Authors:  Rita Khoury; George T Grossberg
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.